Search results
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: American Express,...
Zacks via Yahoo Finance· 5 days agoStocks recently featured in the blog include: American Express Co. AXP, Walmart Inc. WMT, Amazon.com...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 17 hours agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 2 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck & Co...
McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI
VentureBeat· 2 days agoAtropos Health, a healthcare technology company focused on generating personalized real-world...
Lilly partners with Aktis, deepening radiopharma investment
BioPharma Dive via Yahoo Finance· 4 days agoAnd in 2023, Merck & Co’s venture arm participated in the company’s Series A extension, which raised...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 4 days agoBeyond 2030, the drugmaker expects to add radiopharmaceuticals, or hybrid radiation-emitting drugs,...
AltruBio lands up to $225M after shift to immune drug research
BioPharma Dive via Yahoo Finance· 4 days agoThe Phase 2a study AltruBio currently has underway in ulcerative colitis should produce results in...
Two local RNA-focused biotechs merge, plan to go public 'at some point' - Boston Business Journal
The Business Journals· 1 day agoWatertown’s Orna Therapeutics, a circular RNA startup, said Thursday that it will acquire...
Boston radiopharmaceuticals startup inks deal worth up to $1.16B with Lilly - Boston Business...
The Business Journals· 4 days agoA Boston radiopharmaceuticals startup that is already backed by three Big Pharma companies now has a...
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
Digital Journal· 3 days agoMedicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, announced today that it ...